---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003054"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T22:30:28.627414+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals converts $150K note into 100K shares; appoints Antonios Isaac as President & Director

## Summary
- Debt conversion with Mill End Capital: $150K promissory note converted to 100K restricted common shares at $1.50/share.
- Antonios Isaac appointed as Director and President; enters 12-month consulting agreement at $10K/month.
- Final 250 shares of Series B Preferred Stock sold for $250K, completing Fourth Closing under 2024 SPA.
- Conversion of note triggers anti-dilution repricing: all outstanding warrants and Series B conversion price adjusted to $1.50/share.

## SEC filing metadata
- accession: 0001493152-25-003054
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.02, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225003054/0001493152-25-003054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225003054/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003054
- JSON: https://secwatch.observer/filing/0001493152-25-003054.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003054.txt

## Key facts
- Executive change
  Antonios Isaac was appointed as President at MANGOCEUTICALS, INC..
  - Action: appointed
  - Role: President
  source text: appointed Antonios Isaac as a member of the Board and as President of the Company, which appointments were effective the same day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1938046/000149315225003054/0001493152-25-003054-index.htm
- Executive change
  Antonios Isaac was appointed as Director at MANGOCEUTICALS, INC..
  - Action: appointed
  - Role: Director
  source text: appointed Antonios Isaac as a member of the Board and as President of the Company, which appointments were effective the same day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1938046/000149315225003054/0001493152-25-003054-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.